approving the antihistamine clemastine (Tavist) for cold symptoms

January 1996

An FDA advisory committee now recommends approving the antihistamine clemastine (Tavist) for cold symptoms. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

momentum building for providing "Continuity of Care."
Diabetes acarbose, a novel drug for type II, or non-insulin-dependent, diabetes
Anticoagulants patients monitor their own warfarin therapy AT HOME
Anticoagulants using the clot-buster t-PA (Activase) for stroke
Anticoagulants ReoPro (abciximab) to inhibit blood clotting
approving the antihistamine clemastine (Tavist) for cold symptoms
Hematology Oncology limit tamoxifen use to 5 years
Hematology Oncology Roche is now marketing Vesanoid
Oral Health some people get fewer canker sores when they switch to a toothpaste that DOESN'T contain sodium lauryl sulfate (SLS)
Oral Health Trental (pentoxifylline) for SEVERE cases of recurrent canker sores
Avonex (interferon beta-1a) for multiple sclerosis
some physicians will prescribe TWO nicotine patches a day
Cholesterol proof that lowering cholesterol reduces the risk of a first heart attack
Cholesterol one cholesterol test isn't enough to determine a patient's cholesterol level
Cardiology the recent concerns about calcium blockers decreasing survival
Ritalin (methylphenidate) for ADHD